EXPRESS SCRIPTS SALES OPERATIONS, INC.
SAINT LOUIS, MO

EXPRESS SCRIPTS SALES OPERATIONS, INC. is an Active company incorporated on January 19, 2017 with the registered number F17000000268. This Foreign for Profit company is located at One Express Way, HQ2E04, Saint Louis, MO, 63121, US and has been running for nine years. There are currently three active principals.

KEY FACTS ABOUT EXPRESS SCRIPTS SALES OPERATIONS, INC.

  1. US Businesses
  2. Companies in Florida
  3. Broward County Companies
Company name
EXPRESS SCRIPTS SALES OPERATIONS, INC.
Status
Active
Filed Number
F17000000268
FEI Number
22-3114423
Date of Incorporation
January 19, 2017
Age - 9 years
Home State
NJ
Company Type
Foreign for Profit

EXPRESS SCRIPTS SALES OPERATIONS, INC. NEAR ME

Principal Address
One Express Way,
HQ2E04,
Saint Louis,
MO,
63121,
US

See Also

EXPRESS SCRIPTS PHARMACEUTICAL PROCUREMENT, LLC EXPRESS SCRIPTS PHARMACY, INC EXPRESS SCRIPTS SERVICES COMPANY EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC. EXPRESS SCRIPTS, INC.

Officers and Directors

The EXPRESS SCRIPTS SALES OPERATIONS, INC. managed by the three persons from Saint Louis on following positions: Director, Secr, Asst

Bradley Phillips

Position
Director Active
From
Saint Louis, MO, MO
Bradley Phillips Related Companies
  1. MAH PHARMACY, L.L.C.
  2. MYMATRIXX-B, LLC
  3. EXPRESS SCRIPTS PHARMACY, INC
  4. MYM TECHNOLOGY & SERVICES, LLC
  5. EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC.
  6. EXPRESS SCRIPTS PHARMACEUTICAL PROCUREMENT, LLC

Geneva Brown

Position
Secr Active
From
Saint Louis, MO, MO
Geneva Brown Related Companies

Mark Fleming

Position
Asst Active
From
Saint Louis, MO, MO
Mark Fleming Related Companies
  1. EXPRESS SCRIPTS PHARMACY, INC
  2. EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC.
  3. EVERNORTH SALES OPERATIONS, INC.
  4. EXPRESS SCRIPTS SERVICES COMPANY
  5. PRIORITY HEALTHCARE CORPORATION
  6. HEALTHBRIDGE REIMBURSEMENT AND PRODUCT SUPPORT, INC.



Registered Agent is C T CORPORATION SYSTEM

Address
1200 SOUTH PINE ISLAND ROAD, PLANTATION, FL, 33324

Annual Reports

2024
April 9, 2024
2023
April 10, 2023